Posted in | News | Gold | Mining Business

Firma Holdings Provides Progress Update on Magistral Project

Firma Holdings Corp. through its subsidiary GracePoint Mining Corp, and in partnership with MX Gold Corp., is pleased to announce that the Magistral project is progressing on schedule. The turn-key build out of the plant includes increasing throughput capacity to 1,000 tonnes per day. The build out is on track to be completed, with the plant operational, by this November.

Mr. Dan Omeniuk, Chairman and CEO of MX Gold stated, "Despite the rainy season in the region, it is encouraging to see that the project business plan is being executed on schedule, and that our Joint Venture efforts with GracePoint are producing positive outcomes. We are looking forward to the projected cash flow from Magistral, as it will serve as an integral part of building value for MX Gold shareholders with a non-dilutive strategy."

Mr. Bert McPherson, President of MX Gold stated, "Combined efforts with GracePoint have also allowed us to seek out potential new acquisitions in the area. We look forward to updating our shareholders after conducting our due diligence in weeks to come."

The project includes a fully permitted 500 TPD Dynamic Cyanide counter current system plant. Construction of the plant was completed in 2013, for approximately $4.5 million. There is a current build out, underway, to bring the plant to 1,000 tonnes per day capacity. Additionally, the Magistral project includes the exclusive rights to process approximately 1.2 million tonnes of mineralized mill tailings, grading an average of 2.06 gold per tonne (79,000 ounces of gold). We are actively sourcing additional toll tailings tonnages and expect to increase project life time near term.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.